| Literature DB >> 35610480 |
Lucy P Aitchison1,2,3, Andy Z L Chen4,5, Clare Toms4, Charbel Sandroussi4,6,7,8, David A Yeo4,8, Daniel Steffens4,7.
Abstract
BACKGROUND: Previous meta-analyses examining skin closure methods for all surgical wounds have found suture to have significantly decreased rates of wound dehiscence compared to tissue adhesive; however, this was not specific to laparoscopic wounds alone. This study aims to determine the best method of skin closure in patients undergoing laparoscopic abdominopelvic surgery in order to minimize wound complications and pain, while maximize cosmesis, time and cost efficiency.Entities:
Keywords: Laparoscopic surgery; Skin closure; Surgical staples; Suture; Tissue adhesive
Mesh:
Substances:
Year: 2022 PMID: 35610480 PMCID: PMC9485090 DOI: 10.1007/s00464-022-09269-9
Source DB: PubMed Journal: Surg Endosc ISSN: 0930-2794 Impact factor: 3.453
Fig. 1Study flow diagram
Fig. 2Risk of bias
Fig. 3Relative risk of postoperative wound dehiscence in randomized controlled trials on efficacy of optimal wound closure of abdominal laparoscopic port sites. Relative risk (RR) < 1 favor intervention group. CI = Confidence intervals
Fig. 4Relative risk of postoperative infection in randomized controlled trials on efficacy of optimal wound closure of abdominal laparoscopic port sites. Relative risk (RR) < 1 favor intervention group. CI = Confidence intervals
Characteristics of the included trials (n = 12)
| Author, year | Study Population | Procedure | Methods of closure | Size of port sites (randomization method) | Outcome measured | Outcome definition | ||
|---|---|---|---|---|---|---|---|---|
| Group I | Group II | Group III (If applicable) | ||||||
| Ben Safta ( | Sample (% male): 70 (32%); Median age (range): 49 (35–62); BMI: NR | Laparoscopic cholecystectomy | Subcuticular 3–0 poliglecaprone | Tissue adhesive 2- octyl cyanoacrylate | NA | Median (range) 25 mm (20–30) (randomized to same patient) | Complications | ND |
| Cosmesis | Patient HWES and POSAS at 1 and 4 weeks; Patient satisfied or not satisfied; VAS | |||||||
| Buchweitz ( | Sample (% male): 56 (0%); Mean age (SD): 35.6 (8.81); Mean BMI (SD): 23.20 (3.92) | Gynecological | Transcutaneous suture 3–0 polypropylene | Tissue adhesive 2-octyl and n-butyl cyanoacrylate blend | NA | 5 mm (randomized to same patient) | Complications | Wound dehiscence, secretions, redness at 7–12 days and 70–90 days |
| Cosmesis | Patient satisfaction with VAS at 70–90 days; Blinded investigator HWES at 70–90 days; Blinded investigator forced choice: which looks better at 7–12 days and 3 months | |||||||
| Pain | VAS at 7–12 days and 70–90 days | |||||||
| Buchweitz ( | Sample (% male): 52 (0%); Mean age (SD): 33.0 (6.70); BMI: NR | Gynecological | Transcutaneous suture 4–0 polyglactin | Subcuticular suture 4–0 polyglactin | Adhesive papertape (Steri-Strip, 3 M Health Care, St Paul, MN, USA) | 5 mm (randomized to same patient) | Complications | Wound infection (confirmed by physician); Wound redness (persisting for ≥ 90 days); Wound dehiscence |
| Cosmesis | Patient VAS at 90 days; Blinded investigator HWES at 90 days | |||||||
| Pain | Presence of pain at 90 days | |||||||
| Chen ( | Sample (% male): 40 (0%); Age (range): 20–68; Mean BMI (range): 22 (19–25) | Gynecological | Subcuticular suture 4–0 poliglecaprone | Tissue adhesive; 2- octyl cyanoacrylate | NA | 5 mm (randomized to same patient) | Complications | Erythema, warmth, drainage, infection |
| Cosmesis | Blinded patient HWES at 14–28 days; Blinded clinician HWES at 14–28 days | |||||||
| Dowson ( | Sample (% male): 154 (34%); Median Age (range): 48 (20–84); BMI: NR | General Surgical (cholecystectomy, inguinal hernia repair, splenectomy, fundoplication) | Transcutaneous suture 3–0 nylon | Tissue adhesive n-butyl-cyanoacrylate | NA | Median (range) 7.7 mm (5-30 mm) (randomized to different patients) | Complications | Infection defined as ≥ 3 of: erythema, edema, inflammation, drainage, malodor. Wound dehiscence |
| Cosmesis | Blinded investigator HWES at 4–6 weeks and 90 days | |||||||
| Time | From wound closure device pick up to being put down after closure of all wounds | |||||||
| Harold ( | Sample (% male): 48 (NR); Mean Age: 48; BMI: NR | General Surgical (cholecystectomy, fundoplication, Heller myotomy, appendicectomy, splenectomy, diagnostic laparoscopy, adrenalectomy, inguinal hernia repair | Subcuticular suture 4–0 polyglactin | Tissue adhesive 2-octyl cyanoacrylate | Adhesive papertape (Steri-Strip Elastic with Compound Benzoin Tincture, 3 M Health Care, St Paul, MN, USA) | 5 mm (randomized to individual wounds) | Complications | Wound infection |
| Cosmesis | Patient VAS at 1 and 6 weeks; Blinded investigator HWES by photograph at 1 and 6 weeks | |||||||
| Pain | VAS at 1 and 6 weeks | |||||||
| Jan ( | Sample (% male): 114 (0%); Mean Age (SD): 44 (10); Median BMI: 24.5 | Gynecological | Subcuticular suture 3–0 polyglactin | Tissue adhesive butyl and octyl cyanoacrylate blend | NA | 5 mm (randomized to different patients) | Complications | Erythema, edema, pain, inflammation discharge, odor, dehiscence at 2 weeks |
| Cosmesis | Unblinded investigator HWES at 14 days | |||||||
| Jallali ( | Sample (% male): 25 (12%); Median Age: adhesive group 36; suture group 56; BMI: NR | Laparoscopic cholecystectomy | Subcuticular suture 3–0 polyglactin | Tissue adhesive 2-octyl cyanoacrylate | NA | 5 mm and 10 mm (randomized to different patients) | Complications | ND |
| Cosmesis | Unblinded investigator HWES at 6–8 weeks; Blinded plastic surgeon VAS by photograph at 6–8 weeks | |||||||
| Time | Time to close all wounds by a single method. (including dressing application in the suture group, no dressing required in adhesive group) | |||||||
| Maartense ( | Sample (% male): 140 (51%); Mean Age (SEM): 58.7 (2); Mean BMI (SEM): 25.7 (0.9) | General Surgical (cholecystectomy, inguinal hernia repair, fundoplication, diagnostic laparoscopy) | Subcuticular suture poliglecaprone | Tissue adhesive 2-octyl cyanoacrylate | Adhesive papertape (Steri-Strips, Bioplasty/Uroplasty, Geleen, The Netherlands) | 5 mm and 10 mm (randomized to different patients) | Complications | Wound infection with spontaneous drainage or requiring drainage of purulent fluid |
| Cosmesis | Patient VAS at 10–14 days and 3 months; Blinded clinician VAS and HWES at 10–14 days and 3 months | |||||||
| Time | From the time the surgeon was ready to start wound closure to completion of closure | |||||||
| Romero ( | Sample (% male): 49 (59%); Mean Age (Range): 11 (5–15); Mean BMI (SD): 18.8 (3.1) | Laparoscopic appendicectomy | Adhesive papertape (Steri-Strip, 3 M Medica, Neuss Germany) | Tissue adhesive 2-octyl cyanoacrylate | NA | 5 mm and 10 mm (randomized to different patients) | Complications | Wound infection (abscess or erythema > 3 mm perpendicular to incision); Wound dehiscence |
| Cosmesis | Patient satisfaction as yes/no at 10 and 90 days; Blinded surgeon VAS at 90 days by photograph | |||||||
| Pain | Presence of pain at 90 days | |||||||
| Rosen ( | Sample (% male): 54 (0%); Mean Age: NR; BMI: NR | Gynecological | Transcutaneous 3–0 Nylon | Subcuticular 3–0 polyglactin | Adhesive papertape | 5 and 10 mm (randomized to the same patient) | Complications | Inflammation, discharge, wound dehiscence |
| Cosmesis | Patient 5-point scale satisfaction for cosmesis at 4 weeks; Consultant surgeon—poor, satisfactory, perfect | |||||||
| Pain | 5-point pain scale at 5 days | |||||||
| Sebesta ( | Sample (% male): 59 (100%); Mean Age: NR; Mean BMI (SD): 31.31 (6.56) | Urological | Subcuticular suture 5–0 polyglactin or poliglecaprone | Tissue adhesives 2- octyl cyanoacrylate | NA | Mean (SD) total length of incisions: 44.16 mm (2.6 mm) (randomized to different patients) | Complications | Infection, dehiscence, seroma |
HWES Hollander wound elevation scale, ND not defined, NR not reported, POSAS patient and observer scar assessment scale, SD standard deviation, SEM standard error of the mean, VAS visual analog scale
Summary of findings and quality of evidence assessment (GRADE)
| Outcomes (Author, year) | Summary of findings | Quality of evidence assessment (GRADE) | ||||
|---|---|---|---|---|---|---|
| Sample size (no of trials) | Effect size RRa (95% CIb) | Study limitation | Inconsistency | Imprecision | Quality | |
| Infection (Buchweitz, | 104 (1 RCTc) | 0.25 (0.03–2.16) | No limitation | Inconsistency | Imprecision | Low |
| Dehiscence (Buchweitz, | 104 (1 RCT) | 0.2 (0.01–4.07) | No limitation | Inconsistency | Imprecision | Low |
| Erythema (Buchweitz, | 104 (1 RCT) | 0.25 (0.03–2.16) | No limitation | Inconsistency | Imprecision | Low |
| Pain (Buchweitz, | 104 (1 RCT) | 0.25 (0.03–2.16) | No limitation | Inconsistency | Imprecision | Low |
| Infection (Buchweitz, | 231 (2 RCTs) | 1.23 (0.48–3.19) | Limitation | Inconsistency | Imprecision | Very Low |
| Dehiscence (Buchweitz, | 576 (3 RCTs) | 0.67 (0.17–2.53) | Limitation | No inconsistency | Imprecision | Low |
| Erythema (Dowson, | 464 (2 RCTs) | 1.18 (0.77–1.79) | Limitation | No inconsistency | Imprecision | Low |
| Drainage (Dowson, | 464 (2 RCTs) | 0.64 (0.14–3.00) | Limitation | No inconsistency | Imprecision | Low |
| Pain (Dowson, | 464 (2 RCTs) | 1.18 (0.49–2.85) | Limitation | No inconsistency | Imprecision | Low |
| Cosmesis HWES at 90 days (Buchweitz, | 112 (1 RCT) | 1.02 (0.97–1.07) | No limitation | Inconsistency | Imprecision | Low |
| Cosmesis HWES at 14 days (Jan, | 345 (1 RCT) | 1.01 (0.99–1.03) | Limitation | No inconsistency | Imprecision | Low |
| Infection (Maartense, | 316 (2 RCTs) | 0.52 (0.15–1.84) | No limitation | No inconsistency | Imprecision | Moderate |
| Dehiscence (Ben Safta | 288 (2 RCTs) | 0.08 (0.01–0.60) | No limitation | Inconsistency | Imprecision | Low |
| Erythema (Chen, | 150 (2 RCTs) | 0.08 (0.01–0.38) | No limitation | Inconsistency | Imprecision | Low |
| Drainage (Chen, | 298 (2 RCTs) | 3.08 (0.39–24.25) | No limitation | No inconsistency | Imprecision | Moderate |
| Pain (Chen, | 80 (1 RCT) | 16 (2.23–114.98) | No limitation | Inconsistency | Imprecision | Low |
| Patient dissatisfaction (Ben Safta, | 70 (1 RCT) | 0.80 (0.23–2.73) | Limitation | Inconsistency | Imprecision | Very low |
| Cosmesis HWES at 28 days (Ben Safta, | 70 (1 RCT) | 1.15 (0.91–1.46) | Limitation | Inconsistency | Imprecision | Very Low |
| Cosmesis HWES at 42–56 days (Jallali, | 100 (1 RCT) | 1.07 (0.79–1.45) | No limitation | Inconsistency | Imprecision | Low |
| Cosmesis HWES at 90 days (Maartense, | 98 (1 RCT) | 1.27 (1.08–1.49) | No limitation | Inconsistency | Imprecision | Low |
| Infection (Maartense, | 167 (2 RCTs) | 1.09 (0.31–3.80) | Limitation | No inconsistency | Imprecision | Low |
| Erythema (Buchweitz, | 75 (1 RCT) | 4.08 (0.23–72.72) | No limitation | Inconsistency | Imprecision | Low |
| Pain (Buchweitz, | 75 (1 RCT) | 4.08 (0.23–72.72) | No limitation | Inconsistency | Imprecision | Low |
| Cosmesis HWES at 90 days (Maartense, | 98 (1 RCT) | 1.47 (1.18–1.83) | No limitation | Inconsistency | Imprecision | Low |
| Infection (Buchweitz, | 75 (1 RCT) | 0.44 (0.03–6.77) | No limitation | Inconsistency | Imprecision | Low |
| Erythema (Buchweitz, | 75 (1 RCT) | 1.36 (0.06–32.15) | No limitation | Inconsistency | Imprecision | Low |
| Pain (Buchweitz, | 75 (1 RCT) | 1.36 (0.06–32.15) | No limitation | Inconsistency | Imprecision | Low |
| Infection (Maartense, | 137 (2 RCTs) | 1.16 (0.33–4.08) | No limitation | No Inconsistency | Imprecision | Moderate |
| Pain (Romero, | 42 (1 RCT) | 1.82 (1.18–18.55) | No limitation | Inconsistency | Imprecision | Low |
| Cosmesis HWES at 90 days (Maartense, | 98 (1 RCT) | 1.16 (0.89–1.51) | No limitation | Inconsistency | Imprecision | Low |
| Patient dissatisfaction at 10 days (Romero, | 42 (1 RCT) | 2.61 (0.56–12.13) | No limitation | Inconsistency | Imprecision | Low |
| Patient dissatisfaction at 90 days (Romero, | 42 (1 RCT) | 2.65 (0.31–24.14) | No limitation | Inconsistency | Imprecision | Low |
Grading of recommendations, assessment, development and evaluations
a = Relative risk; bConfidence Intervals; cRandomized controlled trials
Fig. 5Relative risk of postoperative wound drainage in randomized controlled trials on efficacy of optimal wound closure of abdominal laparoscopic port sites. Relative risk (RR) < 1 favor intervention group. CI = Confidence intervals
Fig. 6Relative risk for postoperative erythema in randomized controlled trials on efficacy of optimal wound closure of abdominal laparoscopic port sites. Relative risk (RR) < 1 favor intervention group. CI = Confidence intervals
Fig. 7Relative risk of postoperative pain in randomized controlled trials on efficacy of optimal wound closure of abdominal laparoscopic port sites. Relative risk (RR) < 1 favor intervention group. CI = Confidence intervals
Fig. 8Relative risk for postoperative HWES (Hollander Wound Evaluation Score) in randomized controlled trials on efficacy of optimal wound closure of abdominal laparoscopic port sites. Relative risk (RR) < 1 favor intervention group. CI = Confidence intervals
Fig. 9Mean difference for cosmesis as assessed by VAS at 90 days in randomized controlled trials investigating the efficacy of optimal wound closure of abdominal laparoscopic port sites. Negative values favor intervention. MD = Mean difference. CI = Confidence intervals
Fig. 10Relative risk of postoperative dissatisfaction in randomized controlled trials on efficacy of optimal wound closure of abdominal laparoscopic port sites. Relative risk (RR) < 1 favor intervention group. CI = Confidence intervals